Can-Fite BioPharma Stock Forecast

Stock Price Forecast

The 2 analysts with 12-month price forecasts for Can-Fite BioPharma stock have an average target of 14, with a low estimate of 10 and a high estimate of 18. The average target predicts an increase of 845.95% from the current stock price of 1.48.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$10	$14	$18	$18
Change	+575.68%	+845.95%	+1116.2%	+1116.2%

Analyst Ratings

The average analyst rating for Can-Fite BioPharma stock from 2 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	2	2	2	2	2	2
Buy	0	0	0	0	0	0
Hold	0	0	0	0	0	0
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	2	2	2	2	2	2

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $10	Strong Buy	Maintains	$10	+575.68%	Mar 21, 2025
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $10	Strong Buy	Maintains	$10	+575.68%	Mar 20, 2025
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $10	Strong Buy	Maintains	$10	+575.68%	Mar 18, 2025
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $10	Strong Buy	Maintains	$10	+575.68%	Mar 3, 2025
Jason Kolbert D. Boral Capital	D. Boral Capital	Strong Buy Maintains $10	Strong Buy	Maintains	$10	+575.68%	Feb 18, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

3.79M

from 743.00K

409.56%

from 743.00K

Revenue Next Year

3.79M

from 3.79M

EPS This Year

-4.88

from -0.01

EPS Next Year

-4.20

from -4.88

Fiscal Year	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2019	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	2.03M	763.00K	853.00K	810.00K	743.00K	3.79M	3.79M	3.00M
Revenue Growth	-46.81%	-62.45%	11.80%	-5.04%	-8.27%	409.56%	-	-20.66%
EPS	-0.15	-0.04	-0.03	-0.01	-0.01	-4.88	-4.20	1.29
EPS Growth	-	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-	1.15
No. Analysts	-	-	-	-	-	3	3	3

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2024	2025	2026
High	3.9M	3.9M	3.1M
Avg	3.8M	3.8M	3.0M
Low	3.6M	3.6M	2.9M

Revenue Growth

Revenue Growth	2024	2025	2026
High	424.5%	2.9%	-18.3%
Avg	409.6%	-	-20.7%
Low	389.5%	-3.9%	-23.8%

EPS Forecast

EPS	2024	2025	2026
High	-5.03	-4.33	1.32
Avg	-4.88	-4.20	1.29
Low	-4.69	-4.04	1.23

EPS Growth

EPS Growth	2024	2025	2026
High	-	-	-
Avg	-	-	-
Low	-	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.